Previous 10 | Next 10 |
Liminal BioSciences (NASDAQ: LMNL) is one of the best-performing stocks on the public market today. If you want to invest in Liminal BioSciences, or if you simply want to find out more about the company and why it is surging in value, this article should answer all of your q...
Gainers: Golden Nugget Online Gaming (NASDAQ:GNOG) +48%. Tarena International (NASDAQ:TEDU) +43%. SCWorx (NASDAQ:WORX) +32%. Select Interior Concepts (NASDAQ:SIC) +30%. Washington Prime Group (NYSE:WPG) +30%. The9 Limited (NASDAQ:NCTY) +27%. Sphere 3D (NASDAQ:ANY) +26%. Liminal BioSciences (N...
Gainers: SCWorx (NASDAQ:WORX) +32%, Liminal BioSciences (NASDAQ:LMNL) +28%, Allied Healthcare Products (NASDAQ:AHPI) +20%, Windtree Therapeutics (NASDAQ:WINT) +17%, NRx Pharmaceuticals (NASDAQ:NRXP) +15%. Losers: Axsome Therapeutics (NASDAQ:AXSM) -42%,&...
Golden Nugget Online Gaming (NASDAQ:GNOG) +48% DraftKings acquires Golden Nugget Online Gaming in an all-stock deal valued at $1.56B BIT Mining (NYSE:BTCM) +33%. Windtree Therapeutics (NASDAQ:WINT) +33%. Select Interior Concepts (NASDAQ:SIC) +30% an affiliate of Sun Capita...
Liminal BioSciences Announces Sale of Priority Review Voucher for USD105M Canada NewsWire LAVAL, QC and CAMBRIDGE, England , Aug. 9, 2021 /CNW/ - Liminal BioSciences Inc. (Nasdaq: LMNL) ("Liminal BioSciences" or the "Company"), announced today that, i...
Liminal BioSciences (LMNL) has closed on the previously announced divestment of its plasma-derived therapeutics manufacturing subsidiary to Kedrion.The company received a consideration of $5M upon deal closure.Liminal will also be entitled to receive 70% of the net proceeds from a s...
Liminal BioSciences Announces Closing of Sale of Plasma-Derived Therapeutics Manufacturing Facility PR Newswire LAVAL, QC and CAMBRIDGE, England , July 9, 2021 /PRNewswire/ - Liminal BioSciences Inc. (Nasdaq: LMNL) ("Liminal BioSciences" or the "Company"), a ...
LeoPatrizi/iStock via Getty Images AmerisourceBergen buying Parexel is unlikely AmerisourceBergen (ABC) potentially acquiring contract research organization Parexel -- as has been suggested in media reports -- is highly unlikely, according to BofA Securities. Analyst Michael Cherny notes that...
Liminal BioSciences Announces Signature of a Share Purchase Agreement for sale of Remaining Plasma-derived Business with Kedrion Canada NewsWire LAVAL, QC and CAMBRIDGE, England , June 23, 2021 /CNW Telbec/ - Liminal BioSciences Inc. (Nasdaq: LMNL) ("Liminal ...
Gainers: Ra Medical Systems RMED +54%, Liminal BioSciences LMNL +42%, Atossa Therapeutics (ATOS) +27%, Bionano Genomics BNGO +20%, Clover Health Investments (CLOV) +16%.Losers: Cabaletta Bio (CABA) -10%, MacroGenics (MGNX) -8%, Purple Bio...
News, Short Squeeze, Breakout and More Instantly...
Liminal Biosciences Inc Company Name:
LMNL Stock Symbol:
NASDAQ Market:
Liminal Biosciences Inc Website:
Evotec SE (EVO) is expected to report $-0.03 for Q3 2023 Amplifon (AMFPF) is expected to report for Q3 2023 Compass Therapeutics Inc. (CMPX) is expected to report $-0.11 for Q3 2023 Astronics Corp. - Class B (ATROB) is expected to report for Q4 2023 Charge Enterprises Inc. (CRGE) ...
Liminal BioSciences Inc. (LMNL) is expected to report for Q3 2023
LIMINAL BIOSCIENCES ANNOUNCES COMPLETION OF THE PLAN OF ARRANGEMENT WITH STRUCTURED ALPHA LP Canada NewsWire LAVAL, QC and CAMBRIDGE, England , Sept. 26, 2023 /CNW/ - Liminal BioSciences Inc. ("Liminal BioSciences" or the "Company") is pleased to announce tha...